Yipurun (Shanghai) Biotechnology Co., Ltd. is a wholly owned subsidiary of Puyi (Shanghai) Biotechnology Co., Ltd. Leveraging advanced biomedical material transformation processes and proprietary drug–device controlled-release technologies, the company develops and manufactures a portfolio of high-end implantable and interventional medical products.
Puyi Bio and its subsidiaries focus on platform technologies including biodegradable polymer materials and sustained drug-release systems, with products covering multiple therapeutic areas. Driven by continuous innovation to address unmet clinical needs, the company has filed 132 patent applications, including 65 invention patents, with 86 patents granted to date, 22 of which are overseas. Puyi Bio is committed to delivering long-term innovative solutions in women’s health, ENT, and consumer healthcare.
Puyi (Shanghai) Biotechnology Co., Ltd.
enquiry@yipurunbio.com commercial@yipurunbio.com
Room 2206, No. 396, Lishizhen Road, Pudong New Area, Shanghai
